[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@Immuneering](/creator/twitter/Immuneering) "#PancreaticCancer is one of the most challenging cancers to treat. At $IMRX were encouraged by our clinical data featured by @LetsWinPC highlighting the potential of our investigational therapy atebimetinib to help address this urgent unmet need" [X Link](https://x.com/Immuneering/status/1975954410581660023) [@Immuneering](/creator/x/Immuneering) 2025-10-08T16:00Z XXX followers, XXX engagements "Our clinical data featured in @TargetedOnc highlight the potential of our investigational therapy atebimetinib in combination with chemotherapy to help address pancreatic cancer an area of urgent unmet need" [X Link](https://x.com/Immuneering/status/1976316772262244554) [@Immuneering](/creator/x/Immuneering) 2025-10-09T16:00Z XXX followers, XXX engagements "$IMRX and @BenZeskind were honored to join @bradloncar and @BiotechTV live from the NYSE to discuss our latest progress in oncology including promising pancreatic cancer data and our deep cyclic inhibitors. Watch the full video here:" [X Link](https://x.com/Immuneering/status/1976672755870564604) [@Immuneering](/creator/x/Immuneering) 2025-10-10T15:34Z XXX followers, XXX engagements "Meet us in Vienna during #BIOEurope taking place Nov 3-5 Our CBO E.B. Brakewood will be onsite to meet with global business leaders and industry experts in the biotech & pharma fields. Learn more about $IMRX and our pipeline:" [X Link](https://x.com/Immuneering/status/1977766482768519636) [@Immuneering](/creator/x/Immuneering) 2025-10-13T16:00Z XXX followers, XXX engagements "ICYMI: $IMRX ended Sept. with strong momentum: XX% 9-month survival in 1L pancreatic cancer (atebimetinib + mGnP) and a $200M financing including $25M from Sanofi. Webcast replay:" [X Link](https://x.com/Immuneering/status/1978481083717927224) [@Immuneering](/creator/x/Immuneering) 2025-10-15T15:20Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Immuneering
"#PancreaticCancer is one of the most challenging cancers to treat. At $IMRX were encouraged by our clinical data featured by @LetsWinPC highlighting the potential of our investigational therapy atebimetinib to help address this urgent unmet need"
X Link @Immuneering 2025-10-08T16:00Z XXX followers, XXX engagements
"Our clinical data featured in @TargetedOnc highlight the potential of our investigational therapy atebimetinib in combination with chemotherapy to help address pancreatic cancer an area of urgent unmet need"
X Link @Immuneering 2025-10-09T16:00Z XXX followers, XXX engagements
"$IMRX and @BenZeskind were honored to join @bradloncar and @BiotechTV live from the NYSE to discuss our latest progress in oncology including promising pancreatic cancer data and our deep cyclic inhibitors. Watch the full video here:"
X Link @Immuneering 2025-10-10T15:34Z XXX followers, XXX engagements
"Meet us in Vienna during #BIOEurope taking place Nov 3-5 Our CBO E.B. Brakewood will be onsite to meet with global business leaders and industry experts in the biotech & pharma fields. Learn more about $IMRX and our pipeline:"
X Link @Immuneering 2025-10-13T16:00Z XXX followers, XXX engagements
"ICYMI: $IMRX ended Sept. with strong momentum: XX% 9-month survival in 1L pancreatic cancer (atebimetinib + mGnP) and a $200M financing including $25M from Sanofi. Webcast replay:"
X Link @Immuneering 2025-10-15T15:20Z XXX followers, XXX engagements
/creator/twitter::78703821/posts